Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01942668 · ClinicalTrials.gov registry record · Phase 3
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 study of Menopause, sponsored by TherapeuticsMD.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,845
- Enrollment target
- 20
- Study locations
NCT01942668 is a Phase 3 study of Menopause that has completed, run by TherapeuticsMD. The registered enrollment target is 1,845 participants, below the 9,360-participant average among 54 other Menopause trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT01942668, a Phase 3 study of Menopause, has completed, sponsored by TherapeuticsMD.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,845 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will be a prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter trial of postmenopausal subjects with an intact uterus.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Progesterone
- DRUG Estradiol
Study Locations (20)
California
- Sutter East Bay Medical Foundation - Berkeley
- Grossmont Center for Clinical Research - La Mesa
- Futura Research - Norwalk
- Medical Center for Clinical Research - San Diego
- Women's Health Care Research Corp. - San Diego
- Radiant Research, Inc. - Santa Rosa
- Diablo Clinical Research - Walnut Creek
Alabama
- Simon Williamson Clinic - Birmingham
- Medical Affiliated Research Center - Huntsville
- Coastal Clinical Research - Mobile
- Mobile Ob-Gyn, P.C. - Mobile
- Montgomery Women's Health - Montgomery
Arizona
- Advanced Research Associates - Glendale
- Cactus Clinical Research - Mesa
- Precision Trials - Phoenix
- Radiant Research (Tucson) - Tucson
- Visions Clinical Research Tucson - Tucson
Colorado
- Downtown Women's Healthcare - Denver
- Horizon's Clinical Research Center - Denver
Arkansas
- Health Star Research, LLC - Hot Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,845 participants |
| Start Date | 2013-08-05 |
| Est. Completion | 2016-10-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01942668
The ClinicalTrials.gov registry entry for NCT01942668 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,845 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,360-participant average among 54 other Menopause trials with a reported enrollment target (80% lower). The listed sponsor is TherapeuticsMD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT01942668 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT01942668 about?
NCT01942668 is a clinical study titled "A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms". This study will be a prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter trial of postmenopausal subjects with an intact uterus.
What is the current status of trial NCT01942668?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,845 participants. The study started on 2013-08-05. Estimated completion is 2016-10-28.
What conditions does trial NCT01942668 study?
This clinical trial studies the following conditions: Menopause.
What interventions are being tested in trial NCT01942668?
The interventions under investigation include: Placebo (DRUG), Progesterone (DRUG), Estradiol (DRUG).
Who is sponsoring clinical trial NCT01942668?
This trial is sponsored by TherapeuticsMD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01942668 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women
COMPLETED · Phase 3
-
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
COMPLETED · Phase 3
-
Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Apple Women's Health Study
RECRUITING
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.